• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Treatment of chronic post-viral hepatitis C

Treatment of chronic post-viral hepatitis C

Paperback

Medical Reference

ISBN10: 6208716314
ISBN13: 9786208716318
Publisher: Our Knowledge Publishing
Published: Mar 7 2025
Pages: 60
Weight: 0.21
Height: 0.14 Width: 6.00 Depth: 9.00
Language: English
Chronic post-viral hepatitis C is a major public health problem, with around 71 million people infected worldwide. Until 2011, treatment was based on pegylated dual therapy, with a sustained virological response (SVR) rate of between 40% and 80%, depending on the genotype, albeit with a number of contraindications and adverse effects limiting its prescription. The advent of new direct antiviral agents (DAAs) has brought about a metamorphosis in the management of chronic post-viral hepatitis C, with SVR reaching 90-100% and few adverse effects. The aim of our work was to evaluate the efficacy and safety of direct antiviral agents in a cohort of patients with chronic post-viral hepatitis C. This was a descriptive, cross-sectional, prospective study including all patients followed for chronic post-viral hepatitis C in the Nabeul hepato gastroenterology department, and who were included in the national hepatitis C virus eradication program.

Also from

Ben Mohamed, Asma

Also in

Medical Reference